Results 141 to 150 of about 43,118 (240)

Glutamic acid decarboxylase-IgG among T2DM patients with HCMV infection and HbA1c levels

open access: yesDiyala Journal of Medicine, 2018
Background:Prophetic immune marker glutamic acid decarboxylase (GAD) autoantibody is a distinctive diagnosis between Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus. Individuals have diagnose as Latent Autoimmune Diabetes in adults (LADA) has such
Lajan Q Rahman   +3 more
doaj  

Inverse relationship between Epstein-Barr virus serostatus and anti-glutamic acid decarboxylase autoantibody levels. [PDF]

open access: yesImmunol Res
Debuysschere C   +6 more
europepmc   +1 more source

The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis/encephalopathy. [PDF]

open access: yesFront Neurosci, 2022
Hou JY   +11 more
europepmc   +1 more source

Encephalopathy and adrenal insufficiency secondary to anti-glutamic acid decarboxylase antibodies

open access: yesNeurología (English Edition), 2020
J.A. Crespo Burillo   +4 more
doaj   +1 more source

Accuracy of glutamic acid decarboxylase antibodies for the identification of adult-onset type 1 diabetes mellitus: a systematic review and meta-analysis. [PDF]

open access: yesFront Endocrinol (Lausanne)
Shao MM   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy